Institute of Molecular Biomedicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia.
Curr Microbiol. 2011 Jun;62(6):1739-42. doi: 10.1007/s00284-011-9922-4. Epub 2011 Mar 27.
The role of innate immunity in the prevention of urinary tract infection is well-documented. Toll-like receptor 4 (TLR4) is a major determinant of innate immune response. In an animal model of urinary tract infection, bactofection-mediated gene transfer of TLR4 was tested in a preventive approach. Bactofection with TLR4 reduced the colonization with uropathogenic Escherichia coli by 91% in the kidney and by 41% in the bladder. Reduced colonization was associated with lower oxidative stress and expression of monocyte chemoattractant protein-1 and myeloperoxidase in the kidney. Bactofection with TLR4 was successful in the prevention of ascending pyelonephritis. Further studies should focus on long-term effects, the dose response and the potential therapeutic use in models of chronic urinary tract infection.
先天免疫在预防尿路感染中的作用已得到充分证实。Toll 样受体 4(TLR4)是先天免疫反应的主要决定因素。在尿路感染的动物模型中,研究了 bactofection 介导的 TLR4 基因转移在预防中的作用。TLR4 的 bactofection 将肾脏中的尿路致病性大肠杆菌定植减少了 91%,膀胱中的定植减少了 41%。定植减少与肾脏中氧化应激和单核细胞趋化蛋白-1 和髓过氧化物酶表达降低有关。TLR4 的 bactofection 成功预防了上行性肾盂肾炎。进一步的研究应集中在长期效果、剂量反应以及在慢性尿路感染模型中的潜在治疗用途上。